GNRH1 and thalassemia: Furthermore, women with thalassemia more frequently used GnRH agonist protocols (39.7% vs. 29.7%, p < 0.001) and had significantly higher numbers of retrieved oocytes, mature oocytes, and fertilized oocytes (all p < 0.001).